Spelling suggestions: "subject:"salicylate.""
1 |
The metabolic response to salicylateCharnock, John Stewart. January 1961 (has links) (PDF)
Thesis (Ph.D.)--University of Adelaide, 1962. / [Typewritten].
|
2 |
Synthetic approaches to oximidines I and IIRaw, Steven Anthony January 2002 (has links)
No description available.
|
3 |
Preliminary studies of the effect of salicylate and other drugs on horse liver alcohol dehydrogenasePearson, Charles Ray, January 1969 (has links)
Thesis (M.S.)--University of Wisconsin--Madison, 1969. / eContent provider-neutral record in process. Description based on print version record. Includes bibliographical references.
|
4 |
Contributions à l'étude des salicylates de bismuth de l'acide salicylique et de la diathèse urique.Thabuis, F.-A. January 1899 (has links)
Th.--Méd.--Paris, 1899-1900. / Paris, 1899-1900, tome 47, n ° 75.
|
5 |
Pharmacokinetic and biopharmaceutical studies of cyclosporine in the dog and of salicylate in humans.Abdallah, Hisham Youssef. January 1989 (has links)
Cyclosporine (CsA) is commercially available for oral administration as a solution in olive oil with alcohol and an emulsifier. This formulation suffers from the disadvantages of poor and highly variable absorption, objectionable taste and difficulty in measuring the prescribed dose by visually impaired patients. Several oral formulations were prepared and tested in vitro and in vivo in dogs. Based on these preliminary results the dosage form chosen for evaluation was a tablet formulation prepared by direct compression. These tablets were compared to the commercial oil solution placed into soft gelatin capsules. In order to determine absolute bioavailability and to avoid the concern of time-dependent clearance, an intravenous tracer dose of ³H-CsA was simultaneously administered with each oral test product on each of two occasions. Absolute bioavailability was 46.0 ± 11.1% and 45.4 ± 9.9% for the capsules and tablets, respectively. C(max), t(max) and MRT were not significantly different between the two products. No differences were observed in the pharmacokinetics of the intravenously administered CsA in the two experiments which were separated by 8-13 days. The elderly, usually defined as people over 65 years of age, constitute about 12% of the U.S. population. It has been estimated that one out of four elderly people is arthritic and is, therefore, a candidate for chronic salicylate therapy. The pharmacokinetics of salicylate following a single oral solution dose of 600 mg of sodium salicylate were investigated in 22 healthy, nonsmoking male subjects. The plasma concentration and urinary excretion of salicylic acid and its metabolite, salicyluric acid, as well as the urinary excretion of salicyl glucuronides were monitored. Urinary recovery essentially accounted for the administered dose and was not influenced by age, nor was the apparent oral clearance of salicylic acid. Assuming no presystemic elimination, it could be concluded that systemic availability is unaffected by age. An increase in the apparent volume of distribution, V(area), and a decrease in the maximum plasma salicylic acid concentration with age were observed. Renal clearance of salicyluric acid decreased significantly with age and was found to correlate significantly with creatinine clearance.
|
6 |
The metabolic response to salicylateCharnock, John Stewart January 1961 (has links)
[Typewritten] / 300, xiv p. / Title page, contents and abstract only. The complete thesis in print form is available from the University Library. / Thesis (Ph.D.)--University of Adelaide, 1962
|
7 |
Diffusion kinetics of salicylates in human stratum corneumAmin, Mahendra Ishverbhai, January 1967 (has links)
Thesis (Ph. D.)--University of Wisconsin, 1967. / Typescript. Vita. eContent provider-neutral record in process. Description based on print version record. Includes bibliographical references.
|
8 |
A study of the synthesis, antimycotic action, and toxicity of diiodo-para-aminosalicylic acidBethmann, William Miner, 1928- January 1952 (has links)
No description available.
|
9 |
Studies on the physiological action of salicylates [Part I.] Part II. The synthesis of peptides ; Part III. Studies on the toxin of Bacterium tabacum /Graf, Lloyd Herbert, January 1948 (has links)
Thesis (Ph. D.)--University of Wisconsin--Madison, 1948. / Typescript. Vita. eContent provider-neutral record in process. Description based on print version record. Includes bibliographical references.
|
10 |
Modélisation d'un procédé de précipitation : : application à la préparation d'acide salicylique.Franck, Rüdiger, Unknown Date (has links)
Th.--Génie des procédés--Nancy--I.N.P.L., 1985.
|
Page generated in 0.08 seconds